title: Carbon nanofibers have IgE adjuvant capacity but are less potent than nanotubes in promoting allergic airway responses.
abstract: There is a growing concern for the possible health impact of nanoparticles. The main objective of this study was to investigate the allergy-promoting capacity of four different carbon nanofiber (CNF) samples in an injection and an airway mouse model of allergy. Secondly, the potency of the CNF was compared to the previously reported allergy-promoting capacity of carbon nanotubes (CNT) in the airway model. Ultrafine carbon black particles (ufCBP) were used as a positive control. Particles were given together with the allergen ovalbumin (OVA) either by subcutaneous injection into the footpad or intranasally to BALB/cA mice. After allergen booster, OVA-specific IgE, IgG1, and IgG2a in serum were measured. In the airway model, inflammation was determined as influx of inflammatory cells (eosinophils, neutrophils, lymphocytes, and macrophages) and by mediators (MCP-1 and TNF-α present in bronchoalveolar fluid (BALF)). CNF and CNT both increased OVA-specific IgE levels in the two models, but in the airway model, the CNT gave a significantly stronger IgE response than the CNF. Furthermore, the CNT and not the CNF promoted eosinophil lung inflammation. Our data therefore suggest that nanotube-associated properties are particularly potent in promoting allergic responses.
authors.affiliation: Division of Environmental Medicine, Norwegian Institute of Public Health, P.O. Box 4404 Nydalen, 0403 Oslo, Norway.
authors.forename: Unni Cecilie
authors.initials: UC
authors.lastname: Nygaard
authors.forename: Mari
authors.initials: M
authors.lastname: Samuelsen
authors.forename: Calin Daniel
authors.initials: CD
authors.lastname: Marioara
authors.forename: Martinus
authors.initials: M
authors.lastname: Løvik
mesh_terms: D000276:Adjuvants, Immunologic; D000818:Animals; D002244:Carbon / Q000737:chemistry / Q000276:immunology; D004195:Disease Models, Animal; D006967:Hypersensitivity; D007073:Immunoglobulin E / Q000276:immunology* / Q000378:metabolism; D007249:Inflammation / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008168:Lung / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D057139:Nanofibers / Q000008:administration & dosage* / Q000737:chemistry; D037742:Nanotubes, Carbon / Q000737:chemistry*; D010047:Ovalbumin / Q000737:chemistry; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000378:metabolism
chemical_list: D000276:Adjuvants, Immunologic; D037742:Nanotubes, Carbon; D014409:Tumor Necrosis Factor-alpha; D007073:Immunoglobulin E; D002244:Carbon; D010047:Ovalbumin
references.citation: Free Radic Biol Med. 2010 Apr 1;48(7):924-34
references.pmid: 20093178
references.citation: Toxicol Appl Pharmacol. 2001 Sep 15;175(3):191-9
references.pmid: 11559017
references.citation: Clin Exp Allergy. 1997 Mar;27(3):246-51
references.pmid: 9088650
references.citation: Am J Respir Cell Mol Biol. 2009 Mar;40(3):349-58
references.pmid: 18787175
references.citation: Toxicol Sci. 2009 May;109(1):113-23
references.pmid: 19293371
references.citation: Nat Nanotechnol. 2008 Jul;3(7):423-8
references.pmid: 18654567
references.citation: J Nanosci Nanotechnol. 2004 Sep;4(7):716-8
references.pmid: 15570950
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 Oct;295(4):L552-65
references.pmid: 18658273
references.citation: Toxicol Sci. 2004 Dec;82(2):515-24
references.pmid: 15456925
references.citation: J Intern Med. 2010 Jan;267(1):106-18
references.pmid: 20059647
references.citation: Inhal Toxicol. 2000 Jan;12 Suppl 3:365-72
references.pmid: 26368637
references.citation: Methods. 2007 Jan;41(1):72-9
references.pmid: 17161303
references.citation: Ecotoxicology. 2008 Jul;17(5):438-47
references.pmid: 18454314
references.citation: Environ Health Perspect. 2006 Mar;114(3):328-33
references.pmid: 16507453
references.citation: Toxicol Sci. 2010 Jan;113(1):226-42
references.pmid: 19822600
references.citation: Chem Res Toxicol. 2008 Sep;21(9):1690-7
references.pmid: 18636755
references.citation: Scand J Immunol. 2009 May;69(5):421-8
references.pmid: 19508373
references.citation: Occup Environ Med. 2004 May;61(5):442-7
references.pmid: 15090666
references.citation: Nano Lett. 2005 Jan;5(1):157-61
references.pmid: 15792431
references.citation: Allergy. 2002 Dec;57(12):1111-7
references.pmid: 12464038
references.citation: Nat Nanotechnol. 2010 May;5(5):354-9
references.pmid: 20364135
references.citation: Allergy. 1997;52(38 Suppl):52-6; discussion 57-8
references.pmid: 9208060
references.citation: Clin Exp Allergy. 1998 Jun;28(6):702-8
references.pmid: 9677134
references.citation: Toxicology. 2009 May 17;259(3):113-21
references.pmid: 19428951
references.citation: Environ Health Perspect. 2003 Sep;111(12):1471-7
references.pmid: 12948886
references.citation: Toxicol Appl Pharmacol. 2000 May 15;165(1):84-93
references.pmid: 10814556
references.citation: Toxicol Appl Pharmacol. 2009 Jun 15;237(3):306-16
references.pmid: 19371758
references.citation: Toxicol Sci. 2002 Jan;65(1):7-17
references.pmid: 11752680
references.citation: Clin Exp Allergy. 2006 Nov;36(11):1469-79
references.pmid: 17083358